Novo Holdings A/S, an international life science investor and subsidiary of Novo Nordisk Foundation, has acquired Medical Knowledge Group LLC, a portfolio company of Court Square Capital Partners and Aisling Capital. Harris Williams advised MGK in the acquisition.

MKG is an analytics-driven commercialization platform delivering healthcare targeted insights and services to enhance the clinical and commercial potential of biopharmaceutical customer brands. The firm delivers technology-enabled multi-channel marketing services for the marketing, medical affairs and stakeholder relations teams with biopharmaceutical organizations. The firm’s client portfolio contains both niche biotech firms and diagnostic companies and some of the largest firms in the industry.

“The MKG team has done a tremendous job building a premier analytics-driven commercialization services platform with truly differentiated capabilities and solutions in one of the most attractive sectors of outsourced pharmaceutical services,” said Paul Hepper, a managing director at Harris Williams. “It was a pleasure working with the teams at MKG and Court Square on this transaction and we believe the company has found a fantastic new partner in Novo Holdings.”

“The outsourced pharma commercialization services market continues to experience strong growth as biopharmaceutical firms increasingly recognize the value proposition of firms that can utilize differentiated analytics tools to drive outsized results in their commercialization solutions,” said Dan Linsalata, a managing director at Harris Williams. “Differentiated platforms like MKG will continue to benefit disproportionately from the market tailwinds in the sector and we look forward to seeing the company’s continued success and growth in partnership with Novo Holdings.”